NEW FRAMEWORK MEASURES FAIRNESS WHEN DISTRIBUTING VACCINES

Published Mar 20, 2015
Blacksburg, VA, USA – When vaccines are in short supply, public health officials must decide who among the public should be protected against disease – a decision that can hold moral and ethical implications. In order to avoid such concerns, objective methods should be put in place. Researchers at Virginia Tech devised a general framework that will provide objective ways of measuring the efficiency and fairness of public health intervention policies. To test the framework, the researchers simulated a number of vaccine strategies on a synthetic population representative of Montgomery County, Virginia, for an influenza-like outbreak. An SEIR (Susceptible, Exposed, Infected and Recovered) model was used to represent the progression of health states within the host. Many different axioms of fairness were considered to ensure coverage of realistic policy options. The results of the study showed that giving priority to the youngest members of large families leads to a better outcome when containing the spread of influenza. “Efficiency may not always be the end-all strategy when it comes to designing effective vaccine allocation. Fairness can play an important role when distributing medical resources, but up until now this measure of fairness has been rather subjective,” says Achla Marathe, PhD, Professor of Agricultural and Applied Economics at the Virginia Bioinformatics Institute at Virginia Tech, and author of the study. "To achieve an objective public health plan, it is important to consider both fairness and efficiency of intervention policies," says Molly O'Dell, MD, Director of the New River Health District at the Virginia Department of Health, and Adjunct Professor of Population Health sciences at Virginia Tech. The full study, “Fairness versus Efficiency of Vaccine Allocation Strategies,” is published in Value in Health.

Related Stories

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.

ISPOR Celebrates Its 30-Year Anniversary

Mar 24, 2025

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it is celebrating its 30th anniversary in 2025.

Advancing the Economics of Mental Health: A Global Perspective

Mar 12, 2025

Value in Health, the official journal of ISPOR announced the publication of a special themed section of research papers exploring mental health economics, highlighting impacts on caregivers, productivity, and interventions’ cost-effectiveness.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×